N-(2-phenylbenzo[d]oxazol-5-yl)acetamide | 312269-07-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: N-(2-phenylbenzo[d]oxazol-5-yl)acetamide
• 英文别名: 5-acetamido-2-phenylbenzo[d]oxazole；N-(2-phenyl-benzoxazol-5-yl)-acetamide；N-(2-Phenyl-benzoxazol-5-yl)-acetamid；N-(2-phenyl-1,3-benzoxazol-5-yl)acetamide
• CAS: 312269-07-1
• 化学式: C₁₅H₁₂N₂O₂
• 分子量: 252.272
• InChiKey: XHNGWOCUNBNAQR-UHFFFAOYSA-N

物化性质

• 溶解度：
  13.1 [ug/mL]

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  55.1
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  (2,4-二硝基苯基)苯甲酸酯 在 盐酸 、 tin(ll) chloride 作用下， 生成 N-(2-phenylbenzo[d]oxazol-5-yl)acetamide
  参考文献：
  名称：

  Kym, Chemische Berichte, 1899, vol. 32, p. 1428

  摘要：

  DOI：

文献信息

• Cu-Catalyzed Synthesis of Benzoxazole with Phenol and Cyclic Oxime
  作者：Zheng-Hai Wang、Dong-Hui Wang

  DOI：10.1021/acs.orglett.1c04322

  日期：2022.1.21

  A Cu-catalyzed straightforward synthesis of benzoxazoles from free phenols and cyclic oxime esters is reported. The mild reaction conditions tolerate various electron-withdrawing and electron-donating functional groups on both substrates, affording benzoxazoles in moderate to good yields. With this protocol, large-scale syntheses of Ezutromid and Flunoxaprofe in one or two steps are demonstrated. A

  报道了一种由游离酚和环肟酯催化直接合成苯并恶唑的方法。温和的反应条件耐受两种底物上的各种吸电子和给电子官能团，以中等至良好的产率提供苯并恶唑。使用该协议，证明了在一个或两个步骤中大规模合成Ezutromid和Flunoxaprofe 。提出了一种催化机制，包括通过内球电子转移和随后的环化进行铜催化胺化。
• Iron-Catalyzed Sulfur-Promoted Decyanative Redox Condensation of<i>o</i>-Nitrophenols and Arylacetonitriles: An Unprecedented Route to 2-Arylbenzoxazoles
  作者：Thanh Binh Nguyen、Jerome Cheung Lung

  DOI：10.1002/ejoc.201701607

  日期：2018.11.15

  Elemental sulfur and FeCl2·4H2O was found to be a highly efficient catalyst for decyanative redox condensation reactions of o‐nitrophenols with arylacetonitriles to produce a wide range of 2‐arylbenzoxazoles. Elemental sulfur was discovered to be a cyanide scavenger and an external reducing agent.

  发现元素硫和FeCl 2 · 4H 2 O是邻硝基苯酚与芳基乙腈进行脱氰氧化还原缩合反应以生产各种2-芳基苯并恶唑的高效催化剂。发现元素硫是氰化物清除剂和外部还原剂。
• Compounds and Methods for Treating Mammalian Gastrointestinal Microbial Infections
  申请人：Hedstrom Lizbeth K.

  公开号：US20120101096A1

  公开（公告）日：2012-04-26

  Described herein are compounds, and pharmaceutically acceptable salts and prodrugs thereof, which are useful as inhibitors of IMPDH. In certain embodiments, a compound of the invention selectively inhibits a parasitic IMPDH versus a host IMPDH. Further, the invention provides pharmaceutical compositions comprising one or more compounds of the invention. The invention also relates to methods of treating various parasitic and bacterial infections in mammals. Moreover, the compounds may be used alone or in combination with other therapeutic or prophylactic agents, such as anti-virals, anti-inflammatory agents, antimicrobials and immunosuppressants.

  本文描述了一些化合物，以及其药用盐和前药，这些化合物可用作IMPDH的抑制剂。在某些实施例中，本发明的化合物选择性地抑制寄生物IMPDH而不抑制宿主IMPDH。此外，本发明提供了包含一种或多种本发明化合物的药物组合物。本发明还涉及治疗哺乳动物中各种寄生虫和细菌感染的方法。此外，这些化合物可以单独使用或与其他治疗或预防剂（如抗病毒药物、抗炎药物、抗微生物药物和免疫抑制剂）结合使用。
• TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
  申请人：Wynne Graham Michael

  公开号：US20090075938A1

  公开（公告）日：2009-03-19

  There are disclosed compound of Formula (1): A 1 , A 2 , A 3 and A 4 which may be the same or different, represent N or CR 1 , X is a divalent group selected from O, S(O) n , C═W, NR 4 , NC(═O)R 5 and CR 6 R 7 , W is O, S, NR 20 , Y is N or CR 8 , one of R 4 , R 5 , R 6 , R 8 , R 9 and NR 20 represents -L-R 3 , in which L is a single bond or a linker group, additionally, R 1 , R 3 -R 9 , which may be the same or different, independently represent hydrogen or a substituent and R 20 represents hydrogen, hydroxyl, alkyl optionally substituted by aryl, alkoxy optionally substituted by aryl, aryl, CN, optionally substituted alkoxy, optionally substituted aryloxy, optionally substitute alkanoyl, optionally substituted aroyl, NO 2 , NR 30 R 31 , in which R 30 and R 31 , which may be the same or different, represent hydrogen, optionally substituted alkyl or optionally substituted aryl; additionally, one of R 30 and R 31 may represent optionally substituted alkanoyl or optionally substituted aroyl, n represents an integer from 0 to 2, in addition, when an adjacent pair of A 1 -A 4 each represent CR 1 , then the adjacent carbon atoms, together with their substituents may form a ring B, when X is CR 6 R 7 , R 6 and R 7 , together with the carbon atom to which they are attached may form a ring C, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the therapeutic and/or prophylactic treatment of Duchenne muscular dystrophy, Becker muscular dystrophy or cachexia.

  公式（1）的化合物被揭示：A1，A2，A3和A4，它们可以相同或不同，代表N或CR1，X是从O，S（O）n，C═W，NR4，NC（═O）R5和CR6R7中选择的二价基团，W是O，S，NR20，Y是N或CR8，R4，R5，R6，R8，R9和NR20中的一个表示-L-R3，在其中L是单键或连接基团，此外，R1，R3-R9可以相同或不同，独立地表示氢或取代基，R20表示氢，羟基，可以用芳基取代的烷基，可以用芳基取代的烷氧基，芳基，CN，可以用芳基取代的烷氧基，可以用芳基取代的芳氧基，可以用取代基取代的烷酰基，可以用取代基取代的芳酰基，NO2，NR30R31，在其中R30和R31可以相同或不同，表示氢，可选地取代的烷基或可选地取代的芳基；此外，R30和R31中的一个可以表示可选地取代的烷酰基或可选地取代的芳酰基，n表示从0到2的整数，另外，当相邻的A1-A4中的一对表示CR1时，那么相邻的碳原子及其取代基可以形成环B，当X为CR6R7时，R6和R7与它们附着的碳原子一起可以形成环C，或其药学上可接受的盐，在制造用于治疗和/或预防杜氏肌萎缩症，贝克肌萎缩症或消瘦症的药物时使用。
• Drug Combinations for the Treatment of Duchenne Muscular Dystrophy
  申请人：Wynne Graham Michael

  公开号：US20110195932A1

  公开（公告）日：2011-08-11

  Combinations comprising (or consisting essentially of) one or more compounds of formula (1) with one or more ancillary agents, to processes for preparing the combinations, and to various therapeutic uses of the combinations. Also provided are pharmaceutical compositions containing the combinations as well as a method of treatment of Duchenne muscular dystrophy, Becker muscular dystrophy or cachexia using the combinations.

  本发明涉及与一种或多种化合物（1）的一个或多个辅助剂组合的组合物，以制备这些组合物的过程，以及这些组合物的各种治疗用途。还提供了包含这些组合物的制药组合物，以及使用这些组合物治疗杜氏肌营养不良症、贝克肌营养不良症或消瘦的方法。